戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tibiotics (such as tobramycin delivered by a nebulizer).
2 ) and two doses of UTP (20 and 100 mg in the nebulizer).
3 dose of Exosurf aerosolized by an ultrasonic nebulizer.
4 ad to be used instead of the helium-assisted nebulizer.
5 ments, indicating the high robustness of the nebulizer.
6 erosolized for topical delivery using a mesh nebulizer.
7 ation was performed through a vibrating mesh nebulizer.
8 of dissolved metal standards via a pneumatic nebulizer.
9 ion exchange cartridges (AEC) and a homemade nebulizer.
10 ated guides to the respiratory tract using a nebulizer.
11 e extraction phase, 12 muL of xylene, to the nebulizer.
12 cted with analytes (M) generated in a heated nebulizer.
13 x application using an oscillating capillary nebulizer.
14 rog 4 times daily (n = 6), via an ultrasonic nebulizer.
15 ily aerosolized with a commercial compressor nebulizer.
16 for 2 mM matrix solutions with an ultrasonic nebulizer.
17 rs (87-40%) were obtained using regular flow nebulizers.
18 by using commercially available radioaerosol nebulizers.
19 for both the helium-assisted and thermospray nebulizers.
20 ing had minimal or no contamination of their nebulizers.
21 ltophilia was isolated from 4 of 35 home-use nebulizers.
22 ative to solution analysis with conventional nebulizers.
23 es of 0.2-100 microg mL(-1) using one of the nebulizers.
24 ecainide acetate inhalation solution using a nebulizer (30 mg [n=10], 60 mg [n=22], 90 mg [n=21], 120
25 8 and 100%, respectively) and the concentric nebulizer (73 and 97%, respectively).
26  prototype for generation of aerosol using a nebulizer and collection using a cyclone collector was u
27 spectrometer equipped with a microconcentric nebulizer and membrane desolvator was used to provide hi
28 duction is conducted using a high-efficiency nebulizer and spray chamber to achieve transport efficie
29 on in aqueous solution delivered through the nebulizer and the diluent air flow rate.
30 was sustained between a home-built pneumatic nebulizer and the inlet capillary of an Orbitrap mass sp
31                             Two regular flow nebulizers and a total consumption nebulizer (TCN) were
32 f the aerosol cone from the direct injection nebulizers and the nebulizer-spray chamber arrangement c
33  it with a laser ablation unit, a concentric nebulizer, and a droplet-on-demand system for sample int
34 n (FAPCI) source, consisting of a miniflame, nebulizer, and heated tube, was developed to ionize anal
35      The aerosol was generated in a Collison nebulizer, and the particles were dried in a diffusion d
36  positive pressure breathing assist devices, nebulizers, and oxygen compressors) was responsible for
37 s isolated from 3 of [corrected] 35 home-use nebulizers, and Stenotrophomonas maltophilia was isolate
38 inhaled delivery of mAbs with vibrating mesh nebulizers as a promising approach for the treatment of
39 nd ABLC were administered postoperatively by nebulizer at doses of 25 mg and 50 mg, respectively, whi
40  or precision as compared to the thermospray nebulizer at flow rates of up to 1.0 mL/min using isocra
41 ared with that of Ag NPs in a suspension and nebulizer-based ICP-MS.
42            A micro-APCI source with the GDVN nebulizer behaved as a mass-flow-sensitive detector and
43  HNO3 solution and aspirated directly to the nebulizer-burner system of a FAAS instrument using a flo
44 to suggest that ICP-MS operated with regular nebulizers can offer absolute quantification using gener
45  measurements of inhaled mass (percentage of nebulizer charge, mean +/- SEM) ranged from 5.7 +/- 0.5%
46 osol was administered through an Aerotech II nebulizer (CIS-US, Inc., Bedford, MA) mouthpiece.
47 s been implemented using a total consumption nebulizer coupled to inductively coupled plasma mass spe
48 demountable direct injection high-efficiency nebulizer (d-DIHEN), is successfully incorporated for th
49 AG) delivering coarse particles or a medical nebulizer delivering fine particles.
50            The self-aspiration of the heated nebulizer delivers approximately 20 microL/min of the 3.
51                                              Nebulizer delivery of aerosolized aminoglycosides is eff
52 nfection in 75% of participants (3/4), while nebulizer delivery produced infection in 50% (2/4).
53                                              Nebulizers differing by geometrical parameters were fabr
54 ly low-cost direct injection high-efficiency nebulizer (DIHEN) is introduced for argon inductively co
55           A direct-injection high-efficiency nebulizer (DIHEN) is used to couple a thin-layer electro
56 ices: (1) a direct injection high-efficiency nebulizer (DIHEN); (2) a large-bore DIHEN; and (3) a Mic
57 tems: (1) a direct injection high-efficiency nebulizer (DIHEN); (2) a large-bore DIHEN; and (3) a PFA
58               Compared to a direct injection nebulizer (DIN), the DIHEN was easier to operate.
59 than those reported for the direct injection nebulizer (DIN).
60                                          The nebulizer effectively introduces both volatile and less-
61                                              Nebulizer efficiency at a flow rate of 6 L/min was five
62 ed from aerosol generators such as inhalers, nebulizers etc.
63 lacebo (n = 80) via an investigational eFlow nebulizer every 12 hours for 6 months.
64 dministration (a standard nasal spray, and a nebulizer expected to improve OT deposition in nasal are
65          Through the end of 2020, brand-name nebulizers faced generic competition for 62% of all foll
66 n ultrasonic transducer equipped with a mesh nebulizer fitted with a silicone restrictor plate modifi
67 eived exosome inhalation treatment through a nebulizer for 7 consecutive days.
68 esearch may be used to develop smart-tunable nebulizers, for example, by using the measured momentum
69                                            A nebulizer-free coaxial sheath-flow interface completes t
70 trations, was achieved through a 20% lowered nebulizer gas flow for a full suite of commercial PS MPs
71                  High RF power (1500 W), low nebulizer gas flow rates (0.25-0.35 L/min), and low solu
72  the (13)C signal and operating at a lowered nebulizer gas flow to improve sample transport of larger
73                                  Heating the nebulizer gas in spray-only mode allows improved analyte
74 optimization of vaporization temperature and nebulizer gas pressure it was possible to significantly
75 llary blockage and optimally operates at low nebulizer gas pressures compared with the conventional D
76 rated at ambient conditions with nitrogen as nebulizer gas.
77 eir application to deposition studies of two nebulizer-generated aerosols (mass median diameter 1.5 a
78 as 2.5 mL/min, so a conventional thermospray nebulizer had to be used instead of the helium-assisted
79                                     Although nebulizers have been developed for delivery of small mol
80                            A high efficiency nebulizer (HEN) coupled to a heated spray chamber and a
81  concentrations using LC/MS/MS with a heated nebulizer (HN) interface, instead of a TISP interface, i
82 ect using two different interfaces (a heated nebulizer, HN, and ion spray, ISP) under otherwise the s
83 o followed recommended instructions for good nebulizer hygienic practice and paid particular attentio
84 ntum as a feedback control for adjusting the nebulizer, i.e., its operating conditions, its critical
85  large bore-direct injection high efficiency nebulizer (IB-DIHEN) is introduced that is less prone to
86  of column separation to electrospray MS and nebulizer ICP MS.
87 ed cells were generated utilizing a Collison nebulizer in a whole-body Madison Chamber at different h
88 th an integrated stirring system, a Meinhard nebulizer in combination with a heated single-pass spray
89               Mass spectra recorded with the nebulizer in dripping and jetting modes were almost iden
90 e more advantageous than the microconcentric nebulizer in terms of minimizing memory effects and pote
91 d by means of an ultrasonic, pulsed-delivery nebulizer in up to 12 breaths (total, 72 ug) four times
92 ry from metered-dose inhalers (MDIs) and jet nebulizers in an in vitro model of mechanical ventilatio
93 increased aerosol delivery for both MDIs and nebulizers in the mechanically ventilated model by as mu
94 analytes from the liquid to the gas phase, a nebulizer is a critical component of an ion source.
95                                            A nebulizer is employed to encapsulate picoeukaryote algae
96 acerbations in the emergency department, but nebulizers may still have a role in home and inpatient a
97 anisole) jet, which is generated by a heated nebulizer microchip and directed toward the mass spectro
98  inhaled DLPC only, administered through the nebulizer mouthpiece.
99 5.08% (SD) of the initial drug placed in the nebulizer (neb-charge).
100  interface based on an oscillating capillary nebulizer (OCN) is described for direct deposition of el
101 escribes the use of an oscillating capillary nebulizer (OCN) to spray small droplets of matrix aeroso
102 two strains of B. cepacia recovered from the nebulizer of a third patient was also present in the spu
103 d sample, which is directly connected to the nebulizer of an ICP-MS instrument.
104 oup) or 3-mL NaCl, 0.9%, solution in a nasal nebulizer once a day for 12 weeks (control group).
105 m chloride (NaCl), 0.9%, solution in a nasal nebulizer once a day for 12 weeks (INC group) or 3-mL Na
106 od uses a solvent jet generated by a coaxial nebulizer operated at ambient conditions with nitrogen a
107     Compared to the conventional thermospray nebulizer operated at solvent flow rate of 1 mL/min, the
108  free-flowing aerosol generated by a medical nebulizer or atomizer.
109 der of the neb-charge was sequestered in the nebulizer or exhaled.
110  and others was accounted for by spontaneous nebulizers (p = .001), metered dose inhalers (p = .01),
111                                            A nebulizer plume is an efficient way of generating microd
112 ged into an aerosol generated by a pneumatic nebulizer (PN) and introduced into an ICPMS.
113 ined with a conventional crossflow pneumatic nebulizer (PN), equipped with a Scott-type spray chamber
114  chamber set to drying gas flow of 6 mL/min, nebulizer pressure of 5 psi, and drying gas temperature
115 s (capillary voltage, vaporizer temperature, nebulizer pressure) were found to have effects on detect
116 rying gas flow rate, drying gas temperature, nebulizer pressure, and fragmentor voltage were investig
117  Although in the SIM mode ESI-MS parameters (nebulizer pressure, drying gas flow rate, drying gas tem
118 o of (+/-)BOH, two of the ESI-MS parameters (nebulizer pressure, sheath flow rate) were found to have
119 livery efficiency far exceeding conventional nebulizers preventing waste of expensive biologics and l
120 plumbing scheme and a self-aspirating heated nebulizer probe of a corona discharge atmospheric pressu
121                            A helium-assisted nebulizer provided added stability with no loss in accur
122                        The on-chip pneumatic nebulizer provided control of the flow of the electrospr
123                     By incorporating a spray nebulizer sample deposition method to produce uniform sa
124 d from environmental specimens (i.e., from a nebulizer solution and a nebulizer tube).
125 tion from generic competition for brand-name nebulizer solutions (n=13) was 7 years (after subtractin
126 s and regulatory exclusivities on brand-name nebulizer solutions approved for asthma and COPD from 19
127  extensive patent thickets, manufacturers of nebulizer solutions listed fewer patents overall and rel
128  are compared with an established technique, nebulizer SP-ICPMS.
129 from the direct injection nebulizers and the nebulizer-spray chamber arrangement consists of fast (>1
130 IHEN are superior to those of a conventional nebulizer-spray chamber combination, but precision is in
131 (ZIP)-lipid conjugate to greatly enhance the nebulizer stability.
132                                The resulting nebulizer system provides targeted lung delivery efficie
133 nvestigational eFlow-Neos vibrating membrane nebulizer system, 2) bolus administration using the Intu
134 ular flow nebulizers and a total consumption nebulizer (TCN) were tested.
135 ees C evaporator temperature, 77.9 degrees C nebulizer temperature and 1.1 standard litres per minute
136 t composition, organic modifier content, and nebulizer temperature on the photoionization efficiency
137 ent flow rate and composition as well as the nebulizer temperatures on the ionization efficiency of r
138 ent flow rate and composition as well as the nebulizer temperatures on the photoionization efficiency
139 and nonhydrophobic peptides using any of the nebulizers tested.
140                                              Nebulizer therapy is a cornerstone treatment for asthma
141 w rate, extraction time, acid concentration, nebulizer tip to sample surface gap, and morg/maq ratio.
142 uctively coupled plasma (ICP) torch from the nebulizer tip to the site of analytical measurements.
143 rosol field at distances of 5-30 mm from the nebulizer tip where droplet sizes ranged from 6 to 12 mi
144                We use a custom-designed mesh nebulizer to ensure efficient aerosol delivery of peptid
145 red twice daily via an Investigational eFlow nebulizer to recipients of single (SLT) and bilateral lu
146 d, of which six involving 1283 patients used nebulizers to deliver antibiotics.
147 anical ventilation, high-flow nasal cannula, nebulizer treatment, or noninvasive ventilation.
148 cs, 40 (22%) required respiratory inhaler or nebulizer treatments, 41 (22%) used supplemental oxygen,
149 imens (i.e., from a nebulizer solution and a nebulizer tube).
150 icrom for a direct injection high efficiency nebulizer used in inductively coupled plasma spectrometr
151 am-negative bacteria generated from home-use nebulizers used by cystic fibrosis (CF) patients may be
152 ntation of CD with an inexpensive ultrasonic nebulizer (USN) on the basis of a commercial room humidi
153 mass spectrometry (ICPMS) with an ultrasonic nebulizer (USN).
154 ting strategies employed by manufacturers of nebulizer versus inhaler therapy.
155 red to murine lungs through a vibrating mesh nebulizer (VMN).
156                                       A mesh nebulizer was customized to improve IgG 43RCA-G1 deposit
157  the second design, a miniaturized pneumatic nebulizer was fabricated as an integral part of the chip
158 sing a customized investigational eFlow-Neos nebulizer was found to be safe and effective in reducing
159 l propylene glycol) using an AeroTech II jet nebulizer was instituted daily for 12 consecutive days f
160                                     When the nebulizer was operated with O2, greater albuterol delive
161 nebulization chamber and in the conventional nebulizer were brought to make ELSD fully compatible wit
162 on detection limits using the more efficient nebulizer were estimated to be 0.2 ng and 10 ng mL(-1),
163       Sputum cultures for two patients whose nebulizers were contaminated with B. cepacia did not yie
164                        Sixty-nine percent of nebulizers were contaminated, and up to 16 different env
165                                      Various nebulizers were examined and found to be effective in pr
166 a was isolated from 34 patients, none of the nebulizers were positive for the organism.
167 I 75 mg or placebo (three-times daily; eFlow nebulizer) were each followed by a 4-week off-treatment
168 tial diameters ~100 nm, and a vibrating mesh nebulizer, which produces 2-20 mum droplets that are ini
169                       Here, we report on the nebulizer with a gas dynamic virtual nozzle (GDVN) and i
170  a large-bore DIHEN; and (3) a MicroFlow PFA nebulizer with a PFA Scott-type spray chamber.
171  a large-bore DIHEN; and (3) a PFA microflow nebulizer with a PFA Scott-type spray chamber.
172 s in our laboratory using a glass concentric nebulizer with cyclonic spray chamber arrangement.

 
Page Top